Primary gastric lymphoma (PGL) represents a relatively uncommon gastric neoplasm accounting for 5% of all gastric cancers (Conors & Wise, 1974; Contreary et al., 1980) . However stomach is the most common site of extranodal non Hodgkin's lymphomas (Freeman et al., 1972) .
The best treatment for PGL remains uncertain. Although many of the reported series (Fleming et al., 1982; Siu et al., 1982; Shimm et al., 1983) demonstrate that surgical resection with postoperative irradiation is the most effective treatment, the role of chemotherapy as an initial treatment or postoperatively remains to be clarified.
In this article we report our experience with PGL with reference to histology, prognostic factors and the results of combination chemotherapy with or without gastric resection.
Materials and methods

Patients
By definition patients with PGL have disease confined to stomach or stomach and its draining nodes without evidence of dissemination and with normal peripheral blood at the time of diagnosis (Carr & Hancock, 1984) . Applying these criteria we were able to identify a total of 29 patients Correspondence: T. Economopoulos. Received 26 February 1985; and One patient had a palpable node in the left supraclavicular fossa at presentation but since extensive staging procedures failed to demonstrate disease elsewhere, stomach apart, this patient was not excluded from the study.
The slides of the initial histology were reviewed in all cases, the diagnosis of non-Hodgkin's lymphoma was verified and the cases were finally classified according to the modified Rappaport Classification (1966) .
Median follow up of the 29 patients was 29 months with a minimum of 18 months (range 18-79 months).
Staging
All patients were extensively staged on the basis of clinical examination, surgical or endoscopial findings, X-rays of the chest and upper gastrointestinal (GI) tract, full blood count, liver function tests, bone marrow biopsy, liver biopsy, lymphogram, CT-scan of the abdomen and bone scan.
They were classified according to the Ann-Arbor System (Carbone et al., 1971) KaplanMeier (1958) . The significance of differences between the various actuarial survival curves was assessed by the long rank test.
Results
The patients comprised 20 men and 9 women and the median age of the whole population was 55 years (range, 21-74 (Table IV) . Eighteen (62%) patients had limited disease (Stages I, 111A, II1B) and 11 (48%) disseminated disease (stages 112B and IV) ( Table V) .
All patients with stage IV were classified as such by virtue of liver involvement.
Size situation and local invasion of the tumour Size of the tumour varied from 2 cm to 15 cm in its greater diameter. We have separated the patients into two groups taking 10 cm as an arbitrary dividing line. The distribution is shown in Response to treatment Altogether 18 patients (62%) were found to have a CR during full restaging after the completion of 6 courses of chemotherapy (Table VIII) . Among these, 15 had been treated postoperatively after having had a curative gastric resection. Only 3 patients among the complete responders had been treated with CT without having had a previous gastric resection. Among the 20 patients who had gastric resection 15 (75%) were found to be in CR, 4 (20%) were found to be in PR and one patient (5%) was a non responder (Table VIII) . Contrariwise, among the 9 patients with nonresected tumour 3 (33%) were found to be in CR, 4 (44, 5%) were found to be in PR and 2 (22%) patients were non-responders.
Among the complete responders two patients have relapsed so far. One belongs to the group of patients with resected tumour and he relapsed locally 6 months after CR had been documented. The other belongs to the group of patients with nonresected tumour. He relapsed in the small intestine 20 months after documentation of CR. He was operated upon and the entire macroscopic disease was successfully resected. No evidence of lymphoma was found in the stomach or elsewhere.
The patient has been currently receiving chemotherapy with Pro-MACE regimen (Fisher et al., 1982) . The remaining 16 patients are still in complete remission.
Survival
The survival of all 29 patients is shown in Figure 1 . Median survival has not been reached. Acturial analysis predicts that it will be in excess of 5 years with 58% of patients alive at that time. Among the complete responders 84% are predicted to be alive at 4 years, whereas only 18% of the partial responders and none of the non-responders are predicted to survive, at 28 months. Survival and modality of treatment The group of patients, treated with gastrectomy plus chemotherapy had a significantly better survival (P< 0.05) than the group treated by chemotherapy alone (Figure 2 ). The type of chemotherapy (CHOP vs COP) had no significant influence on survival.
Survival and extent of the disease Size of tumour was found to be an important prognostic discriminant. Those with tumours <10cm had a better survival than those with tumours > 10 cm (P < 0.05 - Figure 3 ). the past few years (Lim et al., 1977; Lewin et al., __ -1978; Hermann et al., 1980; Weingrand et al., 1982; Brooks & Enterline, 1983) By contrast our study comprises 29 patients r size <nOcm (II alive, 2 dead)s (a) tumour treated in a single institution. While we used Ocm (7 alive1 9 dead).
Rappaport's scheme for the classification of lymphoma, all patients were staged using the AnnArbor system. Moreover, we treated all our patients of invasion was less discriminatory. uniformly with multi-chemotherapy, combined with h the group of patients with invasion of the "curative" surgery where feasible. id less well than those with invasion limited
For the above reasons we feel that our results are submucosa or muscularis propia, the of particular interest. ,e was not statistically significant.
Our clinical and radiological findings as well as nfluence of stage is shown in Figure 4 . age and sex distribution do not differ essentially with limited disease (stages IA, II1A, II1B) from those published in other series (Lim et al., better survival than those with advanced 1977; Lewin et al., 1978; Hermann et al., 1980) . stages 112B and IV -P<0.05).
It is of interest to note however, that clinical Ln survival for patients with limited disease examination was not contributory in 86% of our attained at 6 years while it was 26 months cases while on the other hand dysphagia was found with advanced disease. to be a rare presenting complaint. 1982). In addition even a diagnostic endoscopy usually fails to histologically subclassify this lymphoma, and is never satisfactory for staging purposes.
As far as the incidence of the various histological categories is concerned our findings are essentially similar to other series (Lim et al., 1977; Lewin et al., 1978; Hermann et al., 1980) . Using Rappaport's Classification, we found that only one patient (3.5%) demonstrated a nodular architectural pattern. The cellular constituent was histiocytic in 55%, lymphocytic in 31 % and mixed in 14% of cases.
Several investigators have claimed that the AnnArbor staging system is inappropriate for staging gastrointestinal lymphomas (Blackledge et al., 1979; Crowther & Rankin, 1982) and other staging systems have been therefore designated (Lim et al., 1977; Crowther & Rankin, 1982) . Although we do not disagree with the statement that the application of the Ann-Arbor system is problematic in some cases of lymphomas, its modified from used in our study proved to be quite useful as a prognostic determinant, in accordance with the findings of others (Rosenfelt & Rosenberg, 1980; Hermann et al., 1980; Weingrand et al., 1982) .
Tumour size also proved to be of clinical importance since among our patients those with primary tumour > 10 cm in diameter had a shorter survival as a population compared with those whose primary tumour was < 10 cm. This difference proved to be statistically significant. Similar conclusions have been reached by other investigators previously (Shiu et al., 1982; Brooks and Enterline, 1983) .
Although we had the opportunity to study accurately the depth of invasion of the gastric wall in 20 patients, who underwent total or subtotal gastrectomy, we were unable to demonstrate any statistically significant correlation between depth of invasion and survival. Our findings here are at variance with those of other series (Lim et al., 1977; Blackledge et al., 1979; Shiu et al., 1982; Brooks & Enterline, 1983 ) demonstrating a negative correlation between depth of invasion of the gastric wall and survival. Possible explanations for this discrepancy are the small numbers in each group of patients and the administration of effective "adjuvant" multichemotherapy in all our cases. A third possibility may be related to the fact that no cases with extension through the serosa into adjacent organs, or complicating fistula or performation, were included in the present series.
What constitutes the best treatment for primary gastric lymphoma is presently a matter of active debate. Most authors claim that surgery plus postoperative irradiation is associated with the best survival in limited disease (Joseph & Lates, 1966; Shiu et al., 1982; Flemming et al., 1982; Shimm et al., 1983) . Nevertheless, since in most series, irradiation is consistently given postoperatively it is hardly possible to estimate its impact on survival. On the other hand chemotherapy alone or in combination with curative surgery and/or irradiation has been has been used only rarely in limited disease (Hande et al., 1978; Wiengrand et al., 1982; Maor et al., 1984) . This relucance possibly stems from the knowledge that complete response rate with chemotherapy is distinctly low in cases of advanced gastrointestinal lymphomas (Hande et al., 1978; Rosenfelt & Rosenberg, 1980) while complications like perforation and gastrointestinal bleeding are not uncommon (Rosenfelt & Rosenberg, 1980; Hermann et al., 1980; Weingrand et al., 1982 (Weingrand et al., 1982) .
Our experience of the use of multichemotherapy as primary treatment in patients with unresected tumours has been similar to that reported in the literature (Hande et al., 1978; Rosenfelt & Rosenberg, 1980) . Only 3 out of 9 such patients i.e. 33% were found to have complete remission after 6 courses of chemotherapy.
Finally no difference in survival has been documented in relation to the chemotherapy regimen. COP and CHOP proved to be equally effective in the present study. This finding nevertheless must be accepted with caution for two reasons: (a) the numbers of patients in each regimen are small and (b) since the assignment to each treatment was not random we tended to treat with CHOP the apparently ill patients.
In conclusion, on the basis of our present findings we believe that: (a) curative surgery must be always attempted in patients with primary gastric lymphoma; (b) postoperative multichemotherapy is essential in all patients found to have more than stage I disease. The need for postoperative chemotherapy in stage I patients has to be investigated in a prospective randomized trial; (c) the combination of curative surgery and multichemotherapy in limited disease is an effective therapeutic approach deserving further evaluation in a prospective setting and (d) patients presenting with unresectable tumour have a worse prognosis despite multichemotherapy.
